The other prominent players in the value chain (but not included in the report) include Eurofins Scientific, Gatc Biotech AG, Macrogen, Inc., Oxford Nanopore Technologies, Ltd., Bio-Rad Laboratories, Inc., DNASTAR, Inc., Biomatters Ltd., New England Biolabs, Inc., and Myriad Genetics, Inc.

The key players operating in the global DNA sequencing market include Abbott Laboratories, Agilent Technologies, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd, Illumina, Inc., LI-COR Biosciences, Inc., Pacific Biosciences of California, Inc., SIEMENS AG, PerkinElmer Inc., and Thermo Fisher Scientific, Inc.

Get more information on this report: Request Sample Pages

Asia-Pacific possesses high growth potential in the DNA sequencing market , owing to increase in awareness about DNA sequencing and rise in DNA sequencing applications. Furthermore, this region is anticipated to experience fast-paced growth, in terms of development and use of DNA sequencing technologies.

Get more information on this report: Request Sample Pages

According to application, the biomarker & cancer segment accounted for the highest share in 2017, due to increase in prevalence of cancer across the globe.

Get more information on this report: Request Sample Pages

Segment review Based on product, the instrument segment is expected to grow at a CAGR of 22.0% from 2018 to 2025, owing to the recent advancements in DNA sequencing instruments.

The DNA sequencing market is segmented based on product, application, technology, end user, and region. Depending on product, the market is classified into consumable, instrument, and service. The applications covered in the study include biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and others. By technology, the market is divided into, sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real-time sequencing, chain termination sequencing, and nanopore sequencing. Region wise, it is studied across North America (U.S. and rest of North America), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Saudi Arabia, and rest of LAMEA).

Get more information on this report: Request Sample Pages

DNA sequencing is a technology in which several DNA strands can be sequenced through massive parallelization. This sequencing includes both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. Advantages such as low cost, high accuracy & speed, and precise results even from low sample input are offered by DNA sequencing over microarray and other genomic analysis methods. DNA sequencing is used to execute various applications such as biomarker discovery, oncology studies, personalized medicine, forensics, and others. It has streamlined nucleotide analysis and consists of widely replaced conventional tools of genomics, especially microarray, genotyping, and others. The demand for DNA sequencing has increased significantly, owing to surge in sequencing applications and rise in technological advancements in DNA sequencing. In addition, surge in number of genome mapping programs globally and increase in R&D investment drive the market growth.

The global DNA sequencing market was valued at $6,243 million in 2017, and is expected to reach $25,470 million in 2025, registering a CAGR of 19.0% from 2018 to 2025.

Get detailed COVID-19 impact analysis on the Dna Sequencing Market

Pandemic disrupted the entire world and affected many industries.

CHAPTER 1: INTRODUCTION

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top investment pockets

3.3. Top winning strategies

3.4. Market share analysis

3.4.1. Overview

3.5. Patents analysis

3.5.1. Patent analysis, by region

3.5.2. Patent analysis, by year

3.6. Porters five forces analysis

3.7. Market dynamics

3.7.1. Drivers

3.7.1.1. Technological advancements in DNA sequencing

3.7.1.2. Surge in applications of DNA sequencing

3.7.1.3. Increase in partnerships and collaborations

3.7.1.4. Increase in genome mapping programs

3.7.2. Restraints

3.7.2.1. Standardization concerns over DNA sequencing-based diagnostics

3.7.2.2. Dearth of skilled professionals

3.7.2.3. Ethical and legal limitations

3.7.3. Opportunities

3.7.3.1. Lucrative opportunities in emerging markets

3.7.3.2. Cloud computing as a potential data management service

3.7.4. Impact analyses

CHAPTER 4: DNA SEQUENCING MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Consumables

4.2.1. Key market trends, growth factors, and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market analysis, by country

4.3. Instruments

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market analysis, by country

4.4. Services

4.4.1. Key market trends, growth factors, and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market analysis, by country

CHAPTER 5: DNA SEQUENCING MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Biomarker & cancer

5.2.1. Market size and forecast, by region

5.2.2. Market share analysis

5.3. Diagnostics

5.3.1. Market size and forecast, by region

5.3.2. Market share analysis, by country

5.4. Reproductive health

5.4.1. Market size and forecast, by region

5.4.2. Market share analysis, by country

5.5. Personalized medicine

5.5.1. Market size and forecast, by region

5.5.2. Market share analysis, by country

5.6. Forensics

5.6.1. Market size and forecast, by region

5.6.2. Market share analysis

5.7. Others

5.7.1. Market size and forecast, by region

5.7.2. Market share analysis

CHAPTER 6: DNA SEQUENCING MARKET, BY TECHNOLOGY

6.1. Overview

6.1.1. Market size and forecast

6.2. Sequencing by synthesis

6.2.1. Market size and forecast, by region

6.2.2. Market analysis, by country

6.3. Ion semiconductor sequencing

6.3.1. Market size and forecast, by region

6.3.2. Market share analysis, by country

6.4. Sequencing by ligation

6.4.1. Market size and forecast, by region

6.4.2. Market share analysis, by country

6.5. Pyrosequencing

6.5.1. Market size and forecast, by region

6.5.2. Market share analysis, by country

6.6. Single-molecule real-time sequencing

6.6.1. Market size and forecast, by region

6.6.2. Market share analysis, by country

6.7. Chain termination technology

6.7.1. Market size and forecast, by region

6.7.2. Market share analysis, by country

6.8. Nanopore sequencing

6.8.1. Market size and forecast, by region

6.8.2. Market share analysis, by country

CHAPTER 7: DNA SEQUENCING MARKET, BY END USER

7.1. Overview

7.1.1. Market size and forecast

7.2. Academic & government research institute

7.2.1. Market size and forecast, by region

7.2.2. Market share analysis, by country

7.3. Pharmaceutical companies

7.3.1. Market size and forecast, by region

7.3.2. Market share analysis, by country

7.4. Biotechnology companies

7.4.1. Market size and forecast, by region

7.4.2. Market share analysis

7.5. Hospital & clinics

7.5.1. Market size and forecast, by region

7.5.2. Market share analysis

CHAPTER 8: DNA SEQUENCING MARKET, BY REGION

8.1. Overview

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key market trends, growth factors, and opportunities

8.2.2. Market size and forecast, by country

8.2.2.1. U.S.

8.2.2.1.1. U.S. DNA sequencing market, by product

8.2.2.1.2. U.S. DNA sequencing market, by application

8.2.2.1.3. U.S. DNA sequencing market, by technology

8.2.2.1.4. U.S. DNA sequencing market, by end user

8.2.2.2. Canada

8.2.2.2.1. Canada DNA sequencing market, by product

8.2.2.2.2. Canada DNA sequencing market, by application

8.2.2.2.3. Canada DNA sequencing market, by technology

8.2.2.2.4. Canada DNA sequencing market, by end user

8.2.2.3. Mexico

8.2.2.3.1. Mexico DNA sequencing market, by product

8.2.2.3.2. Mexico DNA sequencing market, by application

8.2.2.3.3. Mexico DNA sequencing market, by technology

8.2.2.3.4. Mexico DNA sequencing market, by end user

8.2.3. Market size and forecast, by product

8.2.4. Market size and forecast, by application

8.2.5. Market size and forecast, by technology

8.2.6. Market size and forecast, by end user

8.3. Europe

8.3.1. Key market trends, growth factors, and opportunities

8.3.2. Market size and forecast, by country

8.3.2.1. Germany

8.3.2.1.1. Germany DNA sequencing market, by product

8.3.2.1.2. Germany DNA sequencing market, by application

8.3.2.1.3. Germany DNA sequencing market, by technology

8.3.2.1.4. Germany DNA sequencing market, by end user

8.3.2.2. France

8.3.2.2.1. France DNA sequencing market, by product

8.3.2.2.2. France DNA sequencing market, by application

8.3.2.2.3. France DNA sequencing market, by technology

8.3.2.2.4. France DNA sequencing market, by end user

8.3.2.3. UK

8.3.2.3.1. UK DNA sequencing market, by product

8.3.2.3.2. UK DNA sequencing market, by application

8.3.2.3.3. UK DNA sequencing market, by technology

8.3.2.3.4. UK DNA sequencing market, by end user

8.3.2.4. Italy

8.3.2.4.1. Italy DNA sequencing market, by product

8.3.2.4.2. Italy DNA sequencing market, by application

8.3.2.4.3. Italy DNA sequencing market, by technology

8.3.2.4.4. Italy DNA sequencing market, by end user

8.3.2.5. Spain

8.3.2.5.1. Spain DNA sequencing market, by product

8.3.2.5.2. Spain DNA sequencing market, by application

8.3.2.5.3. Spain DNA sequencing market, by technology

8.3.2.5.4. Spain DNA sequencing market, by end user

8.3.2.6. Rest of Europe

8.3.2.6.1. Rest of Europe DNA sequencing market, by product

8.3.2.6.2. Rest of Europe DNA sequencing market, by application

8.3.2.6.3. Rest of Europe DNA sequencing market, by technology

8.3.2.6.4. Rest of Europe DNA sequencing market, by end user

8.3.3. Market size and forecast, by product

8.3.4. Market size and forecast, by application

8.3.5. Market size and forecast, by technology

8.3.6. Market size and forecast, by end user

8.4. Asia-Pacific

8.4.1. Key market trends, growth factors, and opportunities

8.4.2. Market size and forecast, by country

8.4.2.1. Japan

8.4.2.1.1. Japan DNA sequencing market, by product

8.4.2.1.2. Japan DNA sequencing market, by application

8.4.2.1.3. Japan DNA sequencing market, by technology

8.4.2.1.4. Japan DNA sequencing market, by end user

8.4.2.2. China

8.4.2.2.1. China DNA sequencing market, by product

8.4.2.2.2. China DNA sequencing market, by application

8.4.2.2.3. China DNA sequencing market, by technology

8.4.2.2.4. China DNA sequencing market, by end user

8.4.2.3. Australia

8.4.2.3.1. Australia DNA sequencing market, by product

8.4.2.3.2. Australia DNA sequencing market, by application

8.4.2.3.3. Australia DNA sequencing market, by technology

8.4.2.3.4. Australia DNA sequencing market, by end user

8.4.2.4. India

8.4.2.4.1. India DNA sequencing market, by product

8.4.2.4.2. India DNA sequencing market, by application

8.4.2.4.3. India DNA sequencing market, by technology

8.4.2.4.4. India DNA sequencing market, by end user

8.4.2.5. South Korea

8.4.2.5.1. South Korea DNA sequencing market, by product

8.4.2.5.2. South Korea DNA sequencing market, by application

8.4.2.5.3. South Korea DNA sequencing market, by technology

8.4.2.5.4. South Korea DNA sequencing market, by end user

8.4.2.6. Taiwan

8.4.2.6.1. Taiwan DNA sequencing market, by product

8.4.2.6.2. Taiwan DNA sequencing market, by application

8.4.2.6.3. Taiwan DNA sequencing market, by technology

8.4.2.6.4. Taiwan DNA sequencing market, by end user

8.4.2.7. Rest of Asia-Pacific

8.4.2.7.1. Rest of Asia-Pacific DNA sequencing market, by product

8.4.2.7.2. Rest of Asia-Pacific DNA sequencing market, by application

8.4.2.7.3. Rest of Asia-Pacific DNA sequencing market, by technology

8.4.2.7.4. Rest of Asia-Pacific DNA sequencing market, by end user

8.4.3. Market size and forecast, by product

8.4.4. Market size and forecast, by application

8.4.5. Market size and forecast, by technology

8.4.6. Market size and forecast, by end user

8.5. LAMEA

8.5.1. Key market trends, growth factors, and opportunities

8.5.2. Market size and forecast, by country

8.5.2.1. Brazil

8.5.2.1.1. Brazil DNA sequencing market, by product

8.5.2.1.2. Brazil DNA sequencing market, by application

8.5.2.1.3. Brazil DNA sequencing market, by technology

8.5.2.1.4. Brazil DNA sequencing market, by end user

8.5.2.2. Turkey

8.5.2.2.1. Turkey DNA sequencing market, by product

8.5.2.2.2. Turkey DNA sequencing market, by application

8.5.2.2.3. Turkey DNA sequencing market, by technology

8.5.2.2.4. Turkey DNA sequencing market, by end user

8.5.2.3. Saudi Arabia

8.5.2.3.1. Saudi Arabia DNA sequencing market, by product

8.5.2.3.2. Saudi Arabia DNA sequencing market, by application

8.5.2.3.3. Saudi Arabia DNA sequencing market, by technology

8.5.2.3.4. Saudi Arabia DNA sequencing market, by end user

8.5.2.4. Rest of LAMEA

8.5.2.4.1. Rest of LAMEA DNA sequencing market, by product

8.5.2.4.2. Rest of LAMEA DNA sequencing market, by application

8.5.2.4.3. Rest of LAMEA DNA sequencing market, by technology

8.5.2.4.4. Rest of LAMEA DNA sequencing market, by end user

8.5.3. Market size and forecast, by product

8.5.4. Market size and forecast, by application

8.5.5. Market size and forecast, by technology

8.5.6. Market size and forecast, by end user

CHAPTER 9: COMPANY PROFILES

9.1. ABBOTT LABORATORIES

9.1.1. Company overview

9.1.2. Company snapshot

9.1.3. Operating business segments

9.1.4. Product portfolio

9.1.5. Business performance

9.2. AGILENT TECHNOLOGIES, INC.

9.2.1. Company overview

9.2.2. Company snapshot

9.2.3. Operating business segments

9.2.4. Product portfolio

9.2.5. Business performance

9.2.6. Key strategic moves and developments

9.3. DANAHER CORPORATION (BECKMAN COULTER, INC.)

9.3.1. Company overview

9.3.2. Company snapshot

9.3.3. Operating business segments

9.3.4. Product portfolio

9.3.5. Business performance

9.4. F. HOFFMANN-LA ROCHE LTD.

9.4.1. Company overview

9.4.2. Company snapshot

9.4.3. Operating business segments

9.4.4. Product portfolio

9.4.5. Business performance

9.4.6. Key strategic moves and developments

9.5. ILLUMINA, INC.

9.5.1. Company overview

9.5.2. Company snapshot

9.5.3. Operating business segments

9.5.4. Product Portfolio

9.5.5. Business performance

9.5.6. Key strategic moves and developments

9.6. LI-COR, INC.

9.6.1. Company overview

9.6.2. Company snapshot

9.6.3. Operating business segments

9.6.4. Product portfolio

9.7. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

9.7.1. Company overview

9.7.2. Company snapshot

9.7.3. Operating business segments

9.7.4. Product portfolio

9.7.5. Business performance

9.7.6. Key strategic moves and developments

9.8. PERKINELMER INC.

9.8.1. Company overview

9.8.2. Company snapshot

9.8.3. Operating business segments

9.8.4. Product Portfolio

9.8.5. Business performance

9.9. SIEMENS AG

9.9.1. Company overview

9.9.2. Company snapshot

9.9.3. Operating business segments

9.9.4. Product portfolio

9.9.5. Business performance

9.10. THERMO FISHER SCIENTIFIC, INC.

9.10.1. Company overview

9.10.2. Company snapshot

9.10.3. Operating business segments

9.10.4. Product portfolio

9.10.5. Business performance

9.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 01. GLOBAL DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 02. DNA SEQUENCING MARKET FOR CONSUMABLES, BY REGION, 2016–2023 ($MILLION)

TABLE 03. DNA SEQUENCING MARKET FOR INSTRUMENTS, BY REGION, 2017–2025 ($MILLION)

TABLE 04. DNA SEQUENCING MARKET FOR SERVICES, BY REGION, 2017–2025 ($MILLION)

TABLE 05. GLOBAL DNA SEQUENCING MARKET, BY INDICATION, 2017–2025 ($MILLION)

TABLE 06. DNA SEQUENCING MARKET FOR BIOMARKER AND CANCER, BY REGION, 2017–2025 ($MILLION)

TABLE 07. DNA SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2017–2025 ($MILLION)

TABLE 08. DNA SEQUENCING MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2017–2025 ($MILLION)

TABLE 09. DNA SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2017–2025 ($MILLION)

TABLE 10. DNA SEQUENCING MARKET FOR FORENSICS, BY REGION, 2017–2025 ($MILLION)

TABLE 11. DNA SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2025 ($MILLION)

TABLE 12. GLOBAL DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 13. DNA SEQUENCING MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2017–2025 ($MILLION)

TABLE 14. DNA SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2017–2025 ($MILLION)

TABLE 15. DNA SEQUENCING MARKET FOR SEQUENCING BY LIGATION, BY REGION, 2017–2025 ($MILLION)

TABLE 16. DNA SEQUENCING MARKET FOR PYROSEQUENCING, BY REGION, 2017–2025 ($MILLION)

TABLE 17. DNA SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2017–2025 ($MILLION)

TABLE 18. DNA SEQUENCING MARKET FOR CHAIN TERMINATION TECHNOLOGY, BY REGION, 2017–2025 ($MILLION)

TABLE 19. DNA SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY REGION, 2017–2025 ($MILLION)

TABLE 20. GLOBAL DNA SEQUENCING MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 21. DNA SEQUENCING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTE, BY REGION, 2017–2025 ($MILLION)

TABLE 22. DNA SEQUENCING MARKET FOR PHARMACEUTICAL COMAPNIES, BY REGION, 2017–2025 ($MILLION)

TABLE 23. DNA SEQUENCING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2025 ($MILLION)

TABLE 24. DNA SEQUENCING MARKET FOR HOSPITAL AND CLINICS, BY REGION, 2017–2025 ($MILLION)

TABLE 25. DNA SEQUENCING MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)

TABLE 26. NORTH AMERICA DNA SEQUENCING MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 27. U.S. DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 28. U.S. DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 29. U.S. DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 30. U.S. DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 31. CANADA DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 32. CANADA DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 33. CANADA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 34. CANADA DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 35. MEXICO DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 36. MEXICO DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 37. MEXICO DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 38. MEXICO DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 39. NORTH AMERICA DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 40. NORTH AMERICA DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 41. NORTH AMERICA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 42. NORTH AMERICA DNA SEQUENCING MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 43. EUROPE DNA SEQUENCING MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 44. GERMANY DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 45. GERMANY DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 46. GERMANY DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 47. GERMANY DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 48. FRANCE DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 49. FRANCE DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 50. FRANCE DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 51. FRANCE DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 52. UK DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 53. UK DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 54. UK DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 55. UK DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 56. ITALY DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 57. ITALY DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 58. ITALY DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 59. ITALY DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 60. SPAIN DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 61. SPAIN DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 62. SPAIN DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 63. SPAIN DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 64. REST OF EUROPE DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 65. REST OF EUROPE DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 66. REST OF EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 67. REST OF EUROPE DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 68. EUROPE DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 69. EUROPE DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 70. EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 71. EUROPE DNA SEQUENCING MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 72. ASIA-PACIFIC DNA SEQUENCING MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 73. JAPAN DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 74. JAPAN DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 75. JAPAN DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 76. JAPAN DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 77. CHINA DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 78. CHINA DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 79. CHINA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 80. CHINA DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 81. AUSTRALIA DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 82. AUSTRALIA DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 83. AUSTRALIA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 84. AUSTRALIA DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 85. INDIA DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 86. INDIA DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 87. INDIA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 88. INDIA DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 89. SOUTH KOREA DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 90. SOUTH KOREA DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 91. SOUTH KOREA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 92. SOUTH KOREA DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 93. TAIWAN DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 94. TAIWAN DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 95. TAIWAN DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 96. TAIWAN DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 97. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 98. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 99. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 100. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 101. ASIA-PACIFIC DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 102. ASIA-PACIFIC DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 103. ASIA-PACIFIC DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 104. ASIA-PACIFIC DNA SEQUENCING MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 105. LAMEA DNA SEQUENCING MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 106. BRAZIL DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 107. BRAZIL DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 108. BRAZIL DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 109. BRAZIL DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 110. TURKEY DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 111. TURKEY DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 112. TURKEY DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 113. TURKEY DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 114. SAUDI ARABIA DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 115. SAUDI ARABIA DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 116. SAUDI ARABIA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 117. SAUDI ARABIA DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 118. REST OF LAMEA DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025

TABLE 119. REST OF LAMEA DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025

TABLE 120. REST OF LAMEA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025

TABLE 121. BRAZIL DNA SEQUENCING MARKET, BY END USER, 2017–2025

TABLE 122. LAMEA DNA SEQUENCING MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 123. LAMEA DNA SEQUENCING MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 124. LAMEA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2017–2025 ($MILLION)

TABLE 125. LAMEA DNA SEQUENCING MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 126. ABBOTT: COMPANY SNAPSHOT

TABLE 127. ABBOTT: OPERATING SEGMENTS

TABLE 128. ABBOTT: PRODUCT PORTFOLIO

TABLE 129. AGILENT: COMPANY SNAPSHOT

TABLE 130. AGILENT: OPERATING SEGMENTS

TABLE 131. BD : PRODUCT PORTFOLIO

TABLE 132. DANAHER: COMPANY SNAPSHOT

TABLE 133. DANAHER: OPERATING SEGMENTS

TABLE 134. DANAHER: PRODUCT PORTFOLIO

TABLE 135. ROCHE: COMPANY SNAPSHOT

TABLE 136. ROCHE: OPERATING SEGMENTS

TABLE 137. ROCHE: PRODUCT PORTFOLIO

TABLE 138. ILLUMINA: COMPANY SNAPSHOT

TABLE 139. ILLUMINA: OPERATING SEGMENTS

TABLE 140. ILLUMINA: PRODUCT PORTFOLIO

TABLE 141. LI-COR, INC.: COMPANY SNAPSHOT

TABLE 142. LI-COR, INC.: OPERATING SEGMENTS

TABLE 143. LI-COR, INC.: PRODUCT PORTFOLIO

TABLE 144. PACBIO: COMPANY SNAPSHOT

TABLE 145. PACBIO: PRODUCT PORTFOLIO

TABLE 146. PERKINELMER: COMPANY SNAPSHOT

TABLE 147. PERKINELMER: OPERATING SEGMENTS

TABLE 148. PERKINELMER: PRODUCT PORTFOLIO

TABLE 149. SEIMENS: COMPANY SNAPSHOT

TABLE 150. SEIMENS: PRODUCT SEGMENTS

TABLE 151. SEIMENS: PRODUCT PORTFOLIO

TABLE 152. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

TABLE 153. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS

TABLE 154. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL DNA SEQUENCING MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2014–2018

FIGURE 04. TOP WINNING STRATEGIES, 2014–2018

FIGURE 05. TOP WINNING STRATEGIES: NATURE AND TYPE, 2014–2018

FIGURE 06. GLOBAL DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017

FIGURE 07. NORTH AMERICA DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017

FIGURE 08. EUROPE DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017

FIGURE 09. ASIA-PACIFIC DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017

FIGURE 10. U.S. DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017

FIGURE 11. UK DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017

FIGURE 12. GERMANY DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017

FIGURE 13. AUSTRIA DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017

FIGURE 14. CHINA DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017

FIGURE 15. SINGAPORE DNA SEQUENCING MARKET, MARKET SHARE ANALYSIS, 2017

FIGURE 16. PATENTS ANALYSIS, BY REGION, 2015–2018

FIGURE 17. PATENTS ANALYSIS, BY YEAR, 2015–2018

FIGURE 18. HIGH BARGANING POWER OF BUYERS

FIGURE 19. MODERATE BARGANING POWER OF SUPPLIERS

FIGURE 20. MODERATE THREAT OF SUBSTITUTION

FIGURE 21. MODERATE THREAT OF NEW ENTRANTS

FIGURE 22. MODERATE COMPETITIVE RIVALRY

FIGURE 23. IMPACT ANALYSES

FIGURE 24. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR CONSUMABLES, BY COUNTRY, 2017 & 2025

FIGURE 25. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY, 2017 & 2025

FIGURE 26. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR SERVICES, BY COUNTRY, 2017 & 2025

FIGURE 27. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR BIOMARKET AND CANCER, BY COUNTRY, 2017 & 2025

FIGURE 28. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2017 & 2025

FIGURE 29. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2017 & 2025

FIGURE 30. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2017 & 2025

FIGURE 31. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR FORENSICS, BY COUNTRY, 2017 & 2025

FIGURE 32. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025

FIGURE 33. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR SYNTHESIS BY SEQUENCING, BY COUNTRY, 2017 & 2025

FIGURE 34. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2017 & 2025

FIGURE 35. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR SEQUENCING BY LIGATION, BY COUNTRY, 2017 & 2025

FIGURE 36. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR PYROSEQUENCING, BY COUNTRY, 2017 & 2025

FIGURE 37. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2017 & 2025

FIGURE 38. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR CHAIN TERMINATION TECHNOLOGY, BY COUNTRY, 2017 & 2025

FIGURE 39. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2017 & 2025

FIGURE 40. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTE, BY COUNTRY, 2017 & 2025

FIGURE 41. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017 & 2025

FIGURE 42. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017 & 2025

FIGURE 43. COMPARATIVE ANALYSIS OF DNA SEQUENCING MARKET FOR HOSPITAL AND CLINICS, BY COUNTRY, 2017 & 2025

FIGURE 44. ABBOTT: NET SALES, 2015–2017 ($MILLION)

FIGURE 45. ABBOTT: NET SALES SHARE, BY OPERATING SEGMENT, 2017 (%)

FIGURE 46. ABBOTT: NET SALES SHARE, BY REGION, 2017 (%)

FIGURE 47. AGILENT: REVENUE, 2015–2017 ($MILLION)

FIGURE 48. AGILENT: REVENUE SHARE BY OPERATING SEGMENT, 2017 (%)

FIGURE 49. AGILENT: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 50. DANAHER: NET SALES, 2015–2017 ($MILLION)

FIGURE 51. DANAHER: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 52. DANAHER: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 53. ROCHE: NET SALES, 2015–2017 ($MILLION)

FIGURE 54. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 55. ROCHE: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 56. ILLUMINA: REVENUE, 2015–2017 ($MILLION)

FIGURE 57. ILLUMINA: REVENUE SHARE BY OPERATING SEGMENT, 2017 (%)

FIGURE 58. ILLUMINA: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 59. PACBIO: REVENUE, 2015–2017 ($MILLION)

FIGURE 60. PACBIO: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 61. PERKINELMER: NET SALES, 2015–2017 ($MILLION)

FIGURE 62. PERKINELMER: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 63. PERKINELMER: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 64. SEIMENS: NET SALES, 2015–2017 ($MILLION)

FIGURE 65. SEIMENS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)

FIGURE 66. SEIMENS: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 67. THERMO FISHER SCIENTIFIC: REVENUE, 2015–2017 ($MILLION)

FIGURE 68. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2017 (%)

FIGURE 69. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2017 (%)